NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,022 | +3.3% | 1,463 | +2.3% | 0.02% | -10.5% |
| Q2 2023 | $144,302 | -4.9% | 1,430 | -13.3% | 0.02% | -9.5% |
| Q1 2023 | $151,708 | +96529.3% | 1,649 | -4.6% | 0.02% | -8.7% |
| Q4 2022 | $157 | -99.9% | 1,729 | -6.0% | 0.02% | +9.5% |
| Q3 2022 | $140,000 | -9.1% | 1,839 | +0.5% | 0.02% | -16.0% |
| Q2 2022 | $154,000 | -11.5% | 1,829 | -7.9% | 0.02% | 0.0% |
| Q1 2022 | $174,000 | -10.8% | 1,985 | -11.1% | 0.02% | -7.4% |
| Q4 2021 | $195,000 | -18.1% | 2,233 | -23.4% | 0.03% | -25.0% |
| Q3 2021 | $238,000 | -10.9% | 2,917 | -0.2% | 0.04% | -10.0% |
| Q2 2021 | $267,000 | +3.9% | 2,923 | -2.8% | 0.04% | -4.8% |
| Q1 2021 | $257,000 | -12.6% | 3,008 | -3.2% | 0.04% | -17.6% |
| Q4 2020 | $294,000 | +8.9% | 3,108 | 0.0% | 0.05% | -3.8% |
| Q3 2020 | $270,000 | -7.8% | 3,108 | -7.4% | 0.05% | -14.5% |
| Q2 2020 | $293,000 | +8.5% | 3,358 | +2.3% | 0.06% | -21.5% |
| Q1 2020 | $270,000 | -16.1% | 3,281 | -3.5% | 0.08% | +3.9% |
| Q4 2019 | $322,000 | +5.9% | 3,400 | -2.9% | 0.08% | -1.3% |
| Q3 2019 | $304,000 | -7.0% | 3,500 | -2.3% | 0.08% | -9.4% |
| Q2 2019 | $327,000 | -3.8% | 3,584 | +1.3% | 0.08% | -7.6% |
| Q1 2019 | $340,000 | +21.0% | 3,539 | +7.7% | 0.09% | +5.7% |
| Q4 2018 | $281,000 | -4.7% | 3,285 | -3.8% | 0.09% | +10.1% |
| Q3 2018 | $295,000 | +7.3% | 3,415 | -6.1% | 0.08% | 0.0% |
| Q2 2018 | $275,000 | -25.5% | 3,637 | -20.3% | 0.08% | -28.8% |
| Q1 2018 | $369,000 | -56.3% | 4,565 | -54.6% | 0.11% | -55.1% |
| Q4 2017 | $844,000 | -4.8% | 10,045 | -2.8% | 0.25% | -11.2% |
| Q3 2017 | $887,000 | +0.5% | 10,338 | -2.3% | 0.28% | -2.8% |
| Q2 2017 | $883,000 | -6.1% | 10,583 | -16.3% | 0.29% | -10.3% |
| Q1 2017 | $940,000 | -15.4% | 12,646 | -17.1% | 0.32% | -18.2% |
| Q4 2016 | $1,111,000 | -15.6% | 15,256 | -8.4% | 0.39% | -17.9% |
| Q3 2016 | $1,316,000 | -20.0% | 16,660 | -16.4% | 0.48% | -21.5% |
| Q2 2016 | $1,644,000 | +6.6% | 19,925 | -6.4% | 0.60% | +6.3% |
| Q1 2016 | $1,542,000 | -25.9% | 21,294 | -11.9% | 0.57% | -27.7% |
| Q4 2015 | $2,080,000 | -8.7% | 24,171 | -2.4% | 0.79% | -12.5% |
| Q3 2015 | $2,277,000 | -7.3% | 24,771 | -0.8% | 0.90% | -1.1% |
| Q2 2015 | $2,456,000 | -0.0% | 24,975 | +0.2% | 0.91% | -1.0% |
| Q1 2015 | $2,457,000 | +13.3% | 24,917 | +6.4% | 0.92% | +7.6% |
| Q4 2014 | $2,169,000 | -1.1% | 23,415 | +0.5% | 0.85% | -4.7% |
| Q3 2014 | $2,193,000 | +6.1% | 23,293 | +2.0% | 0.90% | +3.8% |
| Q2 2014 | $2,066,000 | +5.0% | 22,826 | -1.4% | 0.86% | +2.5% |
| Q1 2014 | $1,968,000 | +6.8% | 23,153 | +1.0% | 0.84% | +3.2% |
| Q4 2013 | $1,842,000 | +3.9% | 22,916 | -0.9% | 0.82% | -5.6% |
| Q3 2013 | $1,773,000 | +8.4% | 23,114 | -0.0% | 0.86% | +1.4% |
| Q2 2013 | $1,635,000 | – | 23,118 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |